Chen X, Sun F, Wang X, Feng X, Aref A, Tian Y
Cancer Cell Int. 2025; 25(1):62.
PMID: 39987122
PMC: 11847367.
DOI: 10.1186/s12935-025-03673-6.
Zou J, Xu B, Luo P, Chen T, Duan H
Front Immunol. 2024; 15:1482765.
PMID: 39628486
PMC: 11611751.
DOI: 10.3389/fimmu.2024.1482765.
Shijimaya T, Tahara T, Shimogama T, Yamazaki J, Kobayashi S, Nakamura N
Epigenomics. 2024; 16(21-22):1329-1336.
PMID: 39492780
PMC: 11728328.
DOI: 10.1080/17501911.2024.2418803.
Onyeaghala G, Sharma S, Oyenuga M, Staley C, Milne G, Demmer R
Microorganisms. 2024; 12(8).
PMID: 39203451
PMC: 11357305.
DOI: 10.3390/microorganisms12081609.
Shijimaya T, Tahara T, Yamazaki J, Kobayashi S, Matsumoto Y, Nakamura N
Sci Rep. 2024; 14(1):19525.
PMID: 39174555
PMC: 11341785.
DOI: 10.1038/s41598-024-67410-1.
Dysbiosis Associated With Esophageal Adenocarcinoma-A Novel Method to Detect Tissue-Associated Microbiome.
Balasubramaniam A, Srinivasan S
Gastro Hep Adv. 2024; 1(5):775-776.
PMID: 39131842
PMC: 11307479.
DOI: 10.1016/j.gastha.2022.05.016.
Advances in Molecular and Genetic Technologies and the Problems Related to Their Application in Personalized Medicine.
Nakhod V, Krivenko A, Butkova T, Malsagova K, Kaysheva A
J Pers Med. 2024; 14(6).
PMID: 38929775
PMC: 11204801.
DOI: 10.3390/jpm14060555.
Causal relationships between gut microbrome and digestive system diseases: A two-sample Mendelian randomization study.
Ding W, Chen L, Xia J, Dong G, Song B, Pei B
Medicine (Baltimore). 2024; 103(17):e37735.
PMID: 38669367
PMC: 11049755.
DOI: 10.1097/MD.0000000000037735.
Gut microbiota and their derivatives in the progression of colorectal cancer: Mechanisms of action, genome and epigenome contributions.
Ahmad A, Mahmood N, Raza M, Mushtaq Z, Saeed F, Afzaal M
Heliyon. 2024; 10(8):e29495.
PMID: 38655310
PMC: 11035079.
DOI: 10.1016/j.heliyon.2024.e29495.
Eravacycline, an antibacterial drug, repurposed for pancreatic cancer therapy: insights from a molecular-based deep learning model.
Jabarin A, Shtar G, Feinshtein V, Mazuz E, Shapira B, Ben-Shabat S
Brief Bioinform. 2024; 25(3).
PMID: 38647152
PMC: 11033730.
DOI: 10.1093/bib/bbae108.
Microbiota-Gastric Cancer Interactions and the Potential Influence of Nutritional Therapies.
Raoul P, Maccauro V, Cintoni M, Scarpellini E, Ianiro G, Gasbarrini A
Int J Mol Sci. 2024; 25(3).
PMID: 38338956
PMC: 10855965.
DOI: 10.3390/ijms25031679.
Lung microbiome: new insights into the pathogenesis of respiratory diseases.
Li R, Li J, Zhou X
Signal Transduct Target Ther. 2024; 9(1):19.
PMID: 38228603
PMC: 10791971.
DOI: 10.1038/s41392-023-01722-y.
Microbiome and its implications in oncogenesis: a Mendelian randomization perspective.
Feng K, Ren F, Xing Z, Zhao Y, Yang C, Liu J
Am J Cancer Res. 2024; 13(12):5785-5804.
PMID: 38187050
PMC: 10767327.
Influence of tumor mycobiome on cancer pathogenesis (Review).
Liu W, Li Z, Li X, Cao H, Jiang H, Niu Q
Oncol Lett. 2023; 26(6):541.
PMID: 38020300
PMC: 10660446.
DOI: 10.3892/ol.2023.14128.
Oral squamous cell carcinomas: state of the field and emerging directions.
Tan Y, Wang Z, Xu M, Li B, Huang Z, Qin S
Int J Oral Sci. 2023; 15(1):44.
PMID: 37736748
PMC: 10517027.
DOI: 10.1038/s41368-023-00249-w.
Role of the gut microbiota in hematologic cancer.
Guevara-Ramirez P, Cadena-Ullauri S, Paz-Cruz E, Tamayo-Trujillo R, Ruiz-Pozo V, Zambrano A
Front Microbiol. 2023; 14:1185787.
PMID: 37692399
PMC: 10485363.
DOI: 10.3389/fmicb.2023.1185787.
Intratumor microbiome derived glycolysis-lactate signatures depicts immune heterogeneity in lung adenocarcinoma by integration of microbiomic, transcriptomic, proteomic and single-cell data.
Deng X, Chen X, Luo Y, Que J, Chen L
Front Microbiol. 2023; 14:1202454.
PMID: 37664112
PMC: 10469687.
DOI: 10.3389/fmicb.2023.1202454.
Resident Esophageal Microbiota Dysbiosis Correlates with Cancer Risk in Barrett's Esophagus Patients and Is Linked to Low Adherence to WCRF/AICR Lifestyle Recommendations.
Zaramella A, Arcidiacono D, Nucci D, Fabris F, Benna C, Pucciarelli S
Nutrients. 2023; 15(13).
PMID: 37447211
PMC: 10343580.
DOI: 10.3390/nu15132885.
Current advances in microbial-based cancer therapies.
Shahbaz A, Mahmood T, Javed M, Abbasi B
Med Oncol. 2023; 40(7):207.
PMID: 37330997
DOI: 10.1007/s12032-023-02074-x.
The Rise of Gastrointestinal Cancers as a Global Phenomenon: Unhealthy Behavior or Progress?.
Jardim S, de Souza L, de Souza H
Int J Environ Res Public Health. 2023; 20(4).
PMID: 36834334
PMC: 9962127.
DOI: 10.3390/ijerph20043640.